Overview and Scope
Mantle cell lymphoma therapeutics refers to treatment approaches and strategies used to manage mantle cell lymphoma (MCL); a type of non-Hodgkin lymphoma characterized by abnormal B-cell growth in the lymphatic system. These treatments use focused strategies like BTK and BCL2 inhibitors, which have long-lasting therapeutic effects.
Sizing and Forecast
The mantle cell lymphoma therapeutics market size has grown strongly in recent years. It will grow from $2.26 billion in 2023 to $2.45 billion in 2024 at a compound annual growth rate (CAGR) of 8.5%. The growth in the historic period can be attributed to advances in research, clinical trial success, improved diagnostic tools, treatment access expansion, collaborative research initiatives..
The mantle cell lymphoma therapeutics market size is expected to see strong growth in the next few years. It will grow to $3.29 billion in 2028 at a compound annual growth rate (CAGR) of 7.6%. The growth in the forecast period can be attributed to targeted therapies advancements, immunotherapy innovations, personalized medicine trends, global market expansion, increasing incidence rates.. Major trends in the forecast period include immunotherapy advancements, precision medicine and biomarker development, targeted therapies for specific pathways, combination therapies, integration of artificial intelligence (ai)..
To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/mantle-cell-lymphoma-therapeutics-global-market-report
The mantle cell lymphoma therapeutics market covered in this report is segmented –
1) By Type: Combination Therapy, Monotherapy
2) By Mechanism of Action: Bruton Tyrosine Kinase Inhibitors, Alkylating Agents, Deoxyribonucleic Acid Synthesis Inhibitors, Microtubule Inhibitors, Monoclonal Antibodies, Other Mechanisms
3) By Route of Administration: Oral, Parenteral
4) By Application: Hospital, Research Institute, Other Applications
North America was the largest region in the global mantle cell lymphoma therapeutics market in 2023. The regions covered in the mantle cell lymphoma therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample_request?id=10813&type=smp
Major Driver Impacting Market Growth
The rise in the prevalence of mantle cell lymphoma is expected to propel the growth of the mantle cell lymphoma therapeutics market going forward. Mantle cell lymphoma (MCL) is a type of non-Hodgkin lymphoma (NHL), a cancer affecting the lymphatic system. Mantle Cell Lymphoma therapeutics help reduce the disease’s prevalence by treating and managing the condition and improving patient outcomes, prolonged survival, and reduced disease burden. For instance, in December 2022, according to the National Library of Medicine, a US-based biomedical library operated by the United States Federal Government, the annual incidence of mantle cell lymphoma is one case per 200,000 people, contributing to 5% of all non-Hodgkins lymphomas. Therefore, the rise in the prevalence of mantle cell lymphoma is driving the growth of the mantle cell lymphoma therapeutics market.
Key Industry Players
Major companies operating in the mantle cell lymphoma therapeutics market report are AstraZeneca plc, Celgene Corporation, Johnson & Johnson Consumer Inc., Takeda Pharmaceutical Company Limited, Bayer Aktiengesellschaft, Eli Lilly and Company, Amgen Inc., GlaxoSmithKline plc, Kite Pharma Inc., Gilead Sciences Inc., AbbVie Inc., Bristol-Myers Squibb Company, Novartis AG, Merck & Co. Inc., Massive Bio Inc., Juno Therapeutics Inc., Nurix Therapeutics Inc., Janssen Biotech Inc., TG Therapeutics Inc., F. Hoffmann-La Roche AG, Astex Pharmaceuticals Inc., Astellas Pharma Inc., BeiGene Ltd., Daiichi Sankyo Company Limited, Eisai Co. Ltd., Exelixis Inc., Hutchison China MediTech Limited, Incyte Corporation, Ionis Pharmaceuticals Inc., KalVista Pharmaceuticals Inc.
The mantle cell lymphoma therapeutics market report table of contents includes:
1. Executive Summary
2. Mantle Cell Lymphoma Therapeutics Characteristics
3. Mantle Cell Lymphoma Therapeutics Trends And Strategies
4. Mantle Cell Lymphoma Therapeutics – Macro Economic Scenario
5. Global Mantle Cell Lymphoma Therapeutics Size and Growth
…..
32. Global Mantle Cell Lymphoma Therapeutics Competitive Benchmarking
33. Global Mantle Cell Lymphoma Therapeutics Competitive Dashboard
34. Key Mergers And Acquisitions In The Mantle Cell Lymphoma Therapeutics
35. Mantle Cell Lymphoma Therapeutics Future Outlook and Potential Analysis
36. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
